IFG Advisory’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.5K | Sell |
139
-11,235
| -99% | -$1.92M | 0.07% | 189 |
|
|
2025
Q4 | $1.92M | Buy |
11,374
+7,233
| +175% | +$1.17M | 0.08% | 250 |
|
|
2025
Q3 | $598K | Buy |
4,141
+1,156
| +39% | +$158K | 0.03% | 457 |
|
|
2025
Q2 | $378K | Sell |
2,985
-1,130
| -27% | -$139K | 0.02% | 538 |
|
|
2025
Q1 | $526K | Sell |
4,115
-372
| -8% | -$50.4K | 0.03% | 431 |
|
|
2024
Q4 | $593K | Buy |
+4,487
| New | +$631K | 0.03% | 382 |
|
|
2024
Q3 | – | Sell |
-9,213
| Closed | -$1.26M | – | 486 |
|
|
2024
Q2 | $1.26M | Sell |
9,213
-1,565
| -15% | -$209K | 0.08% | 251 |
|
|
2024
Q1 | $1.48M | Buy |
10,778
+3,579
| +50% | +$489K | 0.11% | 219 |
|
|
2023
Q4 | $978K | Sell |
7,199
-365
| -5% | -$44.5K | 0.07% | 247 |
|
|
2023
Q3 | $925K | Buy |
+7,564
| New | +$962K | 0.08% | 240 |
|
|
2023
Q2 | – | Sell |
-9,996
| Closed | -$1.29M | – | 397 |
|
|
2023
Q1 | $1.29M | Sell |
9,996
-401
| -4% | -$52.5K | 0.12% | 191 |
|
|
2022
Q4 | $1.36M | Buy |
10,397
+661
| +7% | +$85.4K | 0.14% | 165 |
|
|
2022
Q3 | $1.14M | Buy |
9,736
+530
| +6% | +$65.8K | 0.1% | 199 |
|
|
2022
Q2 | $1.08M | Sell |
9,206
-143
| -2% | -$17K | 0.11% | 176 |
|
|
2022
Q1 | $1.22M | Buy |
9,349
+1,542
| +20% | +$201K | 0.12% | 182 |
|
|
2021
Q4 | $1.19M | Buy |
7,807
+351
| +5% | +$54.3K | 0.12% | 185 |
|
|
2021
Q3 | $1.21M | Buy |
7,456
+104
| +1% | +$17.5K | 0.13% | 180 |
|
|
2021
Q2 | $1.2M | Sell |
7,352
-67
| -0.9% | -$10.3K | 0.13% | 177 |
|
|
2021
Q1 | $1.12M | Sell |
7,419
-15
| -0.2% | -$2.38K | 0.14% | 174 |
|
|
2020
Q4 | $1.13M | Buy |
7,434
+297
| +4% | +$42.4K | 0.16% | 153 |
|
|
2020
Q3 | $966K | Buy |
7,137
+1,476
| +26% | +$200K | 0.16% | 157 |
|
|
2020
Q2 | $773K | Buy |
5,661
+2
| +0% | +$255 | 0.14% | 175 |
|
|
2020
Q1 | $609K | Buy |
5,659
+186
| +3% | +$21.4K | 0.14% | 178 |
|
|
2019
Q4 | $659K | Sell |
5,473
-224
| -4% | -$25K | 0.12% | 196 |
|
|
2019
Q3 | $566K | Buy |
5,697
+436
| +8% | +$45.6K | 0.11% | 210 |
|
|
2019
Q2 | $574K | Buy |
5,261
+149
| +3% | +$15.8K | 0.1% | 194 |
|
|
2019
Q1 | $571K | Sell |
5,112
-181
| -3% | -$19.9K | 0.11% | 182 |
|
|
2018
Q4 | $510K | Sell |
5,293
-155
| -3% | -$16.5K | 0.12% | 175 |
|
|
2018
Q3 | $664K | Sell |
5,448
-119
| -2% | -$14K | 0.12% | 161 |
|
|
2018
Q2 | $611K | Buy |
5,567
+19
| +0.3% | +$2.03K | 0.13% | 154 |
|
|
2018
Q1 | $592K | Sell |
5,548
-332
| -6% | -$36.8K | 0.13% | 160 |
|
|
2017
Q4 | $632K | Buy |
+5,880
| New | +$629K | 0.14% | 149 |
|
Other funds holding IBB
CB
IFG Advisory's IBB Position: Q1 2026 in Review
IFG Advisory reduced its iShares Biotechnology ETF (IBB) stake by 99% in Q1 2026, selling an estimated $1.92M and leaving 139 shares worth $23.5K. The position accounts for 0.07% of the portfolio, ranked #189.
IFG Advisory first reported a position in IBB in Q4 2017 and has held it in 32 quarters since. The position peaked at $1.92M in Q4 2025. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- IFG Advisory held 139 shares of iShares Biotechnology ETF worth $23.5K as of Q1 2026.
- IFG Advisory sold 11,235 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.92M.
- iShares Biotechnology ETF made up 0.07% of IFG Advisory's portfolio in Q1 2026, its #189 holding.
- IFG Advisory first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 32 quarters since.
- IFG Advisory's iShares Biotechnology ETF position peaked at $1.92M in Q4 2025.
- 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on IFG Advisory's 13F filing for Q1 2026, filed 12 May 2026.